| Application no. and date | 13869984.8 (espacenet) (Federated) (European Patent Register), 20131014 | | Patent/reg. no. and date | DK/EP 2941251, 20180307 | | Publication date | 20151111 | | Priority no. and date | US 201361749695 P, 20130107 | | EP pub. no. and date |
EP 2941251 20151111 | | Effective date | | | Applicant/owner | Arog Pharmaceuticals, Inc., 5420 LBJ Freeway
Suite 410
Dallas, TX 75240, US | | Applicant ref. no. | V1801-072-DK | | Inventor | JAIN, Vinay, K., 10710 Inwood Road
Dallas, TX 75229, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/4709 (2006.01) , A61K 31/4725 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | CRENOLANIB TIL BEHANDLING AF FLT3 MUTEREDE PROLIFERATIVE LIDELSER | | Int. application no. | US2013064821 | | Int. publication no. | WO2014107209 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
